ROXY SHEFFIELD: Open Payments
NPI 1831456409 · WAYCROSS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,317 in 71 payments from 18 companies in 2025. Trend: 2023 $1,428 · 2024 $1,959 · 2025 $1,317
Food & beverage: $1,317
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $406 |
| PFIZER INC. | 10 | $149 |
| Lilly USA, LLC | 7 | $118 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $112 |
| Axsome Therapeutics, Inc. | 4 | $97 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $82 |
| Novo Nordisk Inc | 3 | $51 |
| Boston Scientific Corporation | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $45 |
| Dexcom, Inc. | 3 | $44 |
Products named: VRAYLAR, NURTEC ODT, BOTOX, CAPLYTA, MOUNJARO, XIFAXAN, Sunosi, General - Pain Management.
Industry payments across GA — which companies pay providers there.
